Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9875430rdf:typepubmed:Citationlld:pubmed
pubmed-article:9875430lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:9875430lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9875430lifeskim:mentionsumls-concept:C0038477lld:lifeskim
pubmed-article:9875430lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9875430lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9875430lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:9875430lifeskim:mentionsumls-concept:C0244485lld:lifeskim
pubmed-article:9875430pubmed:issue2lld:pubmed
pubmed-article:9875430pubmed:dateCreated1999-2-4lld:pubmed
pubmed-article:9875430pubmed:abstractTextA number of substituted isoquinolin-1-ones, possible bioisosteres of the 5-aryl substituted 2,3-dihydroimidazo[2,1-a]isoquinolines, were synthesized and tested for their antitumor activity against five different human tumor cell lines. O-(3-hydroxypropyl) substituted compound (15) exhibited the best antitumor activity which is 3-5 times better than 5-[4'-(piperidinomethyl) phenyl]-2,3-dihydroimidazo[2,1-a]isoquinoline (1).lld:pubmed
pubmed-article:9875430pubmed:languageenglld:pubmed
pubmed-article:9875430pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875430pubmed:citationSubsetIMlld:pubmed
pubmed-article:9875430pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875430pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875430pubmed:statusMEDLINElld:pubmed
pubmed-article:9875430pubmed:monthAprlld:pubmed
pubmed-article:9875430pubmed:issn0253-6269lld:pubmed
pubmed-article:9875430pubmed:authorpubmed-author:ChungB HBHlld:pubmed
pubmed-article:9875430pubmed:authorpubmed-author:HALEW MWMlld:pubmed
pubmed-article:9875430pubmed:authorpubmed-author:ParkJ SJSlld:pubmed
pubmed-article:9875430pubmed:authorpubmed-author:ChoW JWJlld:pubmed
pubmed-article:9875430pubmed:authorpubmed-author:LeeC OCOlld:pubmed
pubmed-article:9875430pubmed:authorpubmed-author:ChungC JCJlld:pubmed
pubmed-article:9875430pubmed:authorpubmed-author:ChoeS YSYlld:pubmed
pubmed-article:9875430pubmed:issnTypePrintlld:pubmed
pubmed-article:9875430pubmed:volume21lld:pubmed
pubmed-article:9875430pubmed:ownerNLMlld:pubmed
pubmed-article:9875430pubmed:authorsCompleteYlld:pubmed
pubmed-article:9875430pubmed:pagination193-7lld:pubmed
pubmed-article:9875430pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9875430pubmed:meshHeadingpubmed-meshheading:9875430-...lld:pubmed
pubmed-article:9875430pubmed:meshHeadingpubmed-meshheading:9875430-...lld:pubmed
pubmed-article:9875430pubmed:meshHeadingpubmed-meshheading:9875430-...lld:pubmed
pubmed-article:9875430pubmed:meshHeadingpubmed-meshheading:9875430-...lld:pubmed
pubmed-article:9875430pubmed:meshHeadingpubmed-meshheading:9875430-...lld:pubmed
pubmed-article:9875430pubmed:meshHeadingpubmed-meshheading:9875430-...lld:pubmed
pubmed-article:9875430pubmed:year1998lld:pubmed
pubmed-article:9875430pubmed:articleTitleSynthesis and structure-activity relationship studies of substituted isoquinoline analogs as antitumor agent.lld:pubmed
pubmed-article:9875430pubmed:affiliationCollege of Pharmacy, Chonnam National University, Kwangju, Korea.lld:pubmed
pubmed-article:9875430pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9875430pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed